Injectable hydrogel as a carrier of vancomycin and a cathelicidin-derived peptide for osteomyelitis treatment

A local drug delivery system that attempts to find a suitable balance between antimicrobial and regenerative actions was developed for osteomyelitis treatment (OM). This system combines the angiogenic and immunomodulatory peptide LLKKK18 (LL18) and vancomycin hydrochloride (VH), loaded into an injec...

ver descrição completa

Detalhes bibliográficos
Autor principal: Machado, Fátima Alexandra Meira (author)
Outros Autores: Pereira, Isabel Sofia Melo (author), Silva, Vanessa (author), Pires, Isabel (author), Prada, Justina (author), Poeta, Patrícia (author), Costa, Luís (author), Pereira, José Eduardo (author), Gama, F. M. (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
Cathelicidin
Dextrin
Hydrogel
Osteomyelitis
Staphylococcus aureus
Vancomycin
Science & Technology
Texto completo:https://hdl.handle.net/1822/79588
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/79588

Texto Completo

https://hdl.handle.net/1822/79588

Registos relacionados